Mark Dolliver's Takes: Big Pharma Is Shifty

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

When people bad-mouth the drug companies—and when do they not?—the word “greedy” figures prominently in their vocabulary. To focus on that one line of complaint, though, is to miss the breadth of public hostility: Consumers think Big Pharma is shifty as well as greedy.

Polling conducted by Harris Interactive for the Pharmaceutical Safety Institute documents the degree to which people don’t trust the industry to disclose bad news about its wares. Asked how confident they are that drugmakers “will eventually disseminate all information—positive or negative—that they have regarding the safety of their drugs,” few said “extremely” (4 percent) or “very” (10 percent).

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Spring Special

Save 30% Off an ADWEEK Subscription Today!

View Your Options

Already a member? Sign in